Concepedia

Susan L. Gawlak

SL

15

Publications

4.4K

Citations

14

H-Index

1989

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Pennsylvania

Bristol-Myers Squibb (Germany)

Susan L. Gawlak is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and tumor biology.

Top concepts

Publications per year

1989–2004

15

Publications

15

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

Scott M. Wilhelm, Christopher Carter, LiYa Tang et al. · Cancer Research · 2004 · 4K citations · Full text

, , +12

Expression and Characterization of Bryodin 1 and a Bryodin 1-Based Single-Chain Immunotoxin from Tobacco Cell Culture

Joseph A. Francisco, Susan L. Gawlak, Michael M. Miller et al. · Bioconjugate Chemistry · 1997 · 66 citations

BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells.

Paula N. Friedman, Stephen J. McAndrew, Susan L. Gawlak et al. · PubMed · 1993 · 50 citations

, , +19

Single-Chain Urokinase Alone or Complexed to Its Receptor in Tetracycline-induced Pleuritis in Rabbits

Steven Idell, Andrew P. Mazar, Douglas B. Cines et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 44 citations

A Region in Domain II of the Urokinase Receptor Required for Urokinase Binding

Khalil Bdeir, Alice A. Kuo, Andrew P. Mazar et al. · Journal of Biological Chemistry · 2000 · 35 citations · Full text

Rows per page

1–5 of 15